Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Novel Point-of-Care Platform for Accurate DOAC Quantification

Objective

MedicQuant ApS is a Danish deep-tech company spun out of Aarhus University in 2019 to address a critical need in emergency medicine: rapid, accurate quantification of small molecules from patient blood samples.
Our initial product addresses a critical unmet need in the treatment of stroke patients who are on Direct Oral Anticoagulants (DOACs).
For these patients, the life-saving thrombolysis therapy cannot be given if DOAC concentrations are too high, due to the elevated risk of fatal intracranial bleeding. Conventional lab tests take over 40 minutes - unacceptable when every 15-minute delay raises mortality 4% and severe disability 7%. Our solution aims to deliver a fast and reliable drug concentrations that empowers clinicians to make safer, faster treatment decisions in these high-stakes scenarios.
Our patent-pending portable platform provides lab-grade accuracy in under ten minutes from a blood sample. A single-use cartridge employs novel flow-front technology, then is read by a stand-alone benchtop instrument, enabling evidence-based management of DOAC strokes within the critical time window. MedicQuant measures individual DOAC levels directly in whole blood, with no sample preparation, via an innovative point-of-care method.
Usability studies at Bispebjerg Hospital (Denmark) and University College London (UK) plus large-scale testing at University Hospital Tübingen (Germany) confirm performance; an instrument is already in use at Bispebjerg Hospital. The technology has won Best Startup (2019), EIT Health MedTech Bootcamp (2020), and an EIC Women-in-TechEU (2023) grant.
By 2030 we aim to embed our test in EU and US stroke guidelines, reach €37 million revenue, and grow to a 41-person team. We will then extend to other DOAC emergencies, additional drug classes - antibiotics, anticancer agents, immunosuppressants - and new regions.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC-ACC - HORIZON EIC Accelerator

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2026-ACCELERATOR-02

See all projects funded under this call

Coordinator

MEDICQUANT APS
Net EU contribution
€ 2 494 930,38
Address
C/O LINE DEBOIS NIELSEN PALLE JUUL-JENSENS BOULEVARD 82
8200 AARHUS N
Denmark
SME
Yes
Region
Danmark Midtjylland Østjylland
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data